¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023³â Á¦3ȸ ´ëÇѳúÇ÷°ü¿Ü°úÇÐȸ ¸ð¾ß¸ð¾ßº´ Çмú´ëȸ : 2023-07-07

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023³â Á¦3ȸ ´ëÇѳúÇ÷°ü¿Ü°úÇÐȸ ¸ð¾ß¸ð¾ßº´ Çмú´ëȸ : 2023-07-07
±³À°ÀÏÀÚ : 2023-07-07
±³À°Àå¼Ò : ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ

±³À°ÁÖÁ¦ : 2023³â Á¦3ȸ ´ëÇѳúÇ÷°ü¿Ü°úÇÐȸ ¸ð¾ß¸ð¾ßº´ Çмú´ëȸ

ÁÖÃÖ±â°ü : ´ëÇѳúÇ÷°ü¿Ü°úÇÐȸ
´ã´çÀÚ : Á¤È¿°æ
¿¬¶ôó : 02-2279-9560  

À̸ÞÀÏ : kscvs@hanmail.net

±³À°Á¾·ù : ½Å°æ¿Ü°ú

Âü¼®¿¹»óÀÎ : 30¸í
Èñ¸ÁÆòÁ¡ : 3Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 30ºÐ

¼¼ºÎ¼ö°­·á : 0¿ø  

ºñ°í ¹«·á


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 14:00~15:00 Specific Issues in Moyamoya Disease - Optimization of recipient artery in revasculizationsurgery for moyamoya disease ¿¬Á¦¿µ(¼º±Õ°ü´ë »ï¼º¼­¿ïº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 15:00~16:00 Specific Issues in Moyamoya Disease - Pregnancy and heredity in patients with moyamoya disease À̽ÿî(ºÐ´ç¼­¿ï´ëº´¿ø ½Å°æ¿Ü°ú)

ÈÞ½Ä 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 16:00~16:30 ÈÞ½Ä ()

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 16:30~16:45 Case Presentation - 1. A Case Report : Development of a new ant.choroidal aneurysm following EDAS in a hemorrhagic Moyamoya patient ÀºÁø(°¡Å縯´ë ÀºÆò¼º¸ðº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 16:45~17:00 Case Presentation - 2. Ruptured aneurysm in moyamoya disease ¿ÀÀç»ó(°¡Å縯´ë ÀÇÁ¤ºÎ¼º¸ðº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 17:00~17:15 Case Presentation - 3. Two cases of complications during bypass surgery for MMS À̼ºÈ£(¼­¿ï´ëº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 17:15~17:30 Case Presentation - 4. Hyperperfusion Syndrome after Triple-Barreled STA-RAG-A1 and STA-MCA Bypass in Moyamoya Angiopathy À嵿±Ô(°¡Å縯´ë ÀÎõ¼º¸ðº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 17:30~17:45 Case Presentation - 5. Transient neurological deterioration due to watershed shift after STA-MCA bypass surgery in Moyamoya disease ÁöűÙ(¼º±Õ°ü´ë »ï¼º¼­¿ïº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 17:45~18:00 Case Presentation - 6. Post OP Delayed ICH due to hyperperfusion after combined bypass surgery to MMD patient ÀÌ»óÈ¿(ºÐ´ç¼­¿ï´ëº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 18:00~18:15 Case Presentation - 7. Mortality case due to postoperative cerebral infarction following bypass surgery in a moyamoya patient ÃÖÁØÈ£(¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 18:15~18:30 Case Presentation - 8. Hydration-induced rapid growth and regression after indirect revascularization of an anterior choroidal artery aneurysm associated with Moyamoya disease: A case report ±èÀåÈÆ(°í·Á´ë ¾È¾Ïº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 18:30~18:45 Case Presentation - 9. Prediction of contralateral progression in nonhemorrhagic moyamoya disease after unilateral surgery ¹æâȯ(Áß¾Ó´ë ±¤¸íº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 18:45~19:00 Case Presentation - 10. Cerebral autoregulatory dysfunction as a main pathophysiology of postoperative cerebral hyperperfusion syndrome in adult moyamoya disease Á¶¿ø»ó(¼­¿ï´ëº´¿ø ½Å°æ¿Ü°ú)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023³â Á¦3ȸ ´ëÇѳúÇ÷°ü¿Ü°úÇÐȸ ¸ð¾ß¸ð¾ßº´ Çмú´ëȸ : 2023-07-07""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦20ȸ ½É±Ù°æ»ö¿¬±¸È¸ ÇÏ°è ½ÉÆ÷Áö¾ö(1ÀÏÂ÷) : 2023-07-07
´ÙÀ½±Û ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø Current status and Challenages of Coronary artery disease and Aortic valvular heart disease : 2023-07-06
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20805 ¼­¿ï 2024 ´ëÇÑ»ê°ú¸¶ÃëÇÐȸ Á¦27Â÷ Çмú´ëȸ : 2024-06-15 0 3 2024-05-27
20804 ÃæºÏ 204 ÃæûºÏµµÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-06-15 0 4 2024-05-27
20803 ºÎ»ê 2024³â Á¦7ȸ ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ Áý´ãȸ : 2024-06-15 0 2 2024-05-27
20802 ºÎ»ê 2024³â ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ ¿öÅ©¼¥-±â´ÉÀû Æò°¡ ¹× ÁßȯÀÚ ÀçÈ°ÀÇ ½ÇÁ¦ (¿Ü»ó ÁßȯÀÚ Æ÷ÇÔ) : 2024-06-15 0 5 2024-05-27
20801 ¼­¿ï KLASS 20Áֳ⠱â³ä 2024 ´ëÇѺ¹°­°æÀ§Àå°ü¿¬±¸È¸ Á¦27ȸ Á¤±âÇмú´ëȸ : 2024-06-15 0 2 2024-05-27
20800 °æ±â 2024³â Á¦ 3ȸ Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-15 0 1 2024-05-27
20799 ¼­¿ï (¿Â¶óÀÎ) 2024³âµµ ÀÓ»óÁø·áÁöħ Æò°¡À§¿ø ¾ç¼º±³À° : 2024-06-15 0 1 2024-05-27
20798 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼҾÆû¼Ò³â°ú ºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-15 0 0 2024-05-27
20797 ¼­¿ï ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ COPD School 2024 : 2024-06-15 0 0 2024-05-27
20796 ¼­¿ï »óóÀå·ç¿¬±¸È¸ Áý´ãȸ : 2024-06-15 0 0 2024-05-27
20795 Àü³² 2024³â Àü¶ó³²µµÀÇ»çȸ Àü¹Ý±â Çмú´ëȸ : 2024-06-15 0 2 2024-05-27
20794 ¼­¿ï Ç÷°ü¿µ»ó»ý¸®¿¬±¸È¸ IPOP(Imaging and Physiology on Patients with Cardiovascular Disease) 2024 : 2024-06-15 0 0 2024-05-27
20793 ¼­¿ï ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ¾à¹°¾Ë·¹¸£±â ½ÉÆ÷Áö¾ö : 2024-06-15 0 1 2024-05-27
20792 ´ëÀü ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ´ëÀü, ÃæûÁöȸ - Á¦3Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-15 0 0 2024-05-27
20791 ¼­¿ï Á¦51ȸ ´ëÇÑÀÓ»óÇǺÎÄ¡·á¿¬±¸È¸ ±³À°½ÉÆ÷Áö¾ö : 2024-06-15 0 4 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷